The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKazera Global Regulatory News (KZG)

Share Price Information for Kazera Global (KZG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.65
Bid: 0.60
Ask: 0.70
Change: 0.00 (0.00%)
Spread: 0.10 (16.667%)
Open: 0.65
High: 0.65
Low: 0.65
Prev. Close: 0.65
KZG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan Facility - Replacement

28 Oct 2021 07:00

RNS Number : 4943Q
Kazera Global PLC
28 October 2021
 

The following amendment has been made to the ' Loan Facility' announcement released on 27.10.2021 at 10:24 under RNS No 4333Q.

Volumes of Tantalum produced will increase with the aim of exceeding 10,000 kilograms per month by the end of 2022, rather than 10,000 tonnes.

All other details remain unchanged.

The full amended text is shown below.

 

 

27 October 2021

Kazera Global plc

("Kazera" or the "Company")

Loan Facility to Fund Transition Into Cash Generation

Kazera Global plc, the AIM quoted investment company, is pleased to announce new financing arrangements that will see the Company through to cash generation over the next 6 months.

 

Highlights

· New loan facility which will allow the Company to draw down up to £250,000 over the next 6 months

· Sums advanced by Westleigh Investments Holdings Limited to be converted into term loan on the same terms

· Deferred director salaries of more than £125,000 converted into term loans on the same basis but subordinated to the above

· Company anticipates that all its existing operations will be trading profitably prior to the end of 2021.

· It further anticipates being cash flow positive in early 2022.

· Within 6 months of the Mining Permit for the Heavy Mineral Sands operation being granted it expects to substantially boost positive cash flow generation.

· Loan facility being put in place to cover any cash flow shortfalls during the next 6 months.

 

 

The Loan Facilities

New Facility

The Company has entered into a new loan facility of £250,000 ("the New Facility") with RiverFort Global Opportunities PCC Limited and Align Research Limited (Align").

The New Facility allows drawdowns over the next 6 months and is repayable at the end of 2022. Sums drawn down on the New Facility attract a fixed interest rate of 5% payable for the period ended 30 April 2022 and 0.5% per month thereafter until the repayment date of 31 Dec 2022. The lenders may also elect to receive this interest in new ordinary shares in the capital of the Company at a deemed price of 2p per share on the repayment date.

Director Loans

In addition, Westleigh Investments Holdings Limited (a company controlled by Giles Clarke and Nick Harrison) has agreed to formalize the arrangements pursuant to which it has financed the Company's operations over recent months into a fixed term loan of £200,0000 repayable at the end of 2022 (the "Westleigh Loan"). The Westleigh Loan ranks pari passu with the New Facility, save that any drawdowns from the New Facility cannot be used for its repayment.

Giles Clarke and Nick Harrison have also agreed that the deferred salaries owing to them of £127,493 will be converted into a fixed term loan repayable at the end of 2022 (the "Deferred Salaries"). The Deferred Salaries are on identical terms to the New Facility however are subordinated and can only be repaid once the New Facility has been repaid.

(together, the "Director Loans").

Warrant Issuance

In consideration for the lenders entering into the New Facility and the Director Loans the Company has agreed to issue warrants (the "Warrants") over:

 

· 28.75m new ordinary shares in the capital of the Company with an exercise price of 2 pence per new ordinary share; and

· 10.65m new ordinary shares in the capital of the Company with an exercise price of 2.7 pence per new ordinary share.

 

In each case, the Warrants will have an expiry date of 30 October 2023.

 

 

The Warrants will be issued as follows:

 

Entity

Warrants at 2p

Warrants at 2.7p

Westleigh Investments

10,000,000

3,703,702

RiverFort Global Opportunities

7,500,000

2,777,776

Giles Clarke & Nick Harrison

6,250,000

2,314,314

Align Research

5,000,000

1,851,851

 

The Company has also agreed to extend the exercise date of the 45,000,000 warrants exercisable at 0.3 pence per new ordinary share currently held by Align (the "Existing Warrants") from 31 March 2022 to 31 March 2023.

 

Forward Strategy

The Company believes that, by the end of 2021, it will have begun to trade profitably and that early in 2022 it will be cash flow positive.

The grant of the Mining Permit for HMS is also now expected before the end of the calendar year. The Company has recently been asked to provide an environmental rehabilitation guarantee, which is apparently one of the last steps prior to the Permit being granted. With the Permit in hand, the Company, as previously announced, expects within 6 months, to begin generating additional profits of up to $300,000 per month. These numbers will be improved even further by introducing a third party to build and operate a separation plant for which discussions are already underway. Simultaneously, the Company is pursuing an application for a Prospecting Right over an area which is approximately 34 times larger than the current site.

Diamond production will also increase as Heavy Mineral Sands are mined, with an estimated increase in diamond production of an additional 300ct per month and with an enhanced value of approximately $750 per carat anticipated.

In Namibia, the expectation is to export the first commercial delivery of Tantalum before the end of the year. Volumes will then steadily increase with the aim of exceeding 10,000 kilograms per month by the end of 2022.

Simultaneously, the focus will be on establishing further mineral reserves as well as on developing the Company's Lithium opportunities.

 

Dennis Edmonds, Kazera Chief Executive Officer, commented: 

"This New Facility, together with the conversion of the current director advances into a fixed term loan, will provide the Company with a cash buffer to overcome any short-term cash issues which might otherwise have hindered its route to profitability and cash generation. There are a number of hurdles to jump before starting to generate serious cash flow, and we now have the resources to do that.

Generating cash from early next year will mean that we can fund our own future expansion and that we would only look to additional funding if it was on terms that substantially improved the Company's prospects.

Particularly exciting for me is the not the fact that we anticipate soon being cash generative, but that we have such enormous potential within our existing operations to build the Company into a genuine success story."

 

Related Party Transactions

Align is committing £100,000 to the New Facility and will be issued with 6,851,851 Warrants as described above. The Company has also agreed to extend the exercise date of the Existing Warrants. Align is a substantial shareholder in the Company and therefore a related party pursuant to Rule 13 of the AIM Rules for Companies.

Together Westleigh, Giles Clarke and Nicholas Harrison will be committing an aggregate of £327,493 to the Company pursuant to the Director Loans. Westleigh, Giles Clarke and Nicholas Harrison will also be issued with an aggregate of 22,268,016 Warrants as described above. Westleigh is ultimately owned by Giles Clarke and Nick Harrison who are directors of the Company. Accordingly, Westleigh, Giles Clarke and Nicholas Harrison are related parties of the Company pursuant to Rule 13 of the AIM Rules for Companies.

The independent directors of Kazera, having consulted with the Company's Nominated Adviser finnCap, consider that the entry into the New Facility with Align, the Directors Loans with Westleigh, Giles Clarke and Nicholas Harrison, the issuance of Warrants to each of those parties and the extension to the Existing Warrants are fair and reasonable insofar as the Company's shareholders are concerned.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No. 596/2014 ('MAR').

 

For further information on the Company, visit: www.kazeraglobal.com

 

Kazera Global plc (c/o Camarco)

Dennis Edmonds (CEO)

Tel: +44 (0)203 757 4980

 

finnCap (Nominated Adviser and Joint Broker)

Christopher Raggett / Charlie Beeson (corporate finance)

 

Tel: +44 (0)207 220 0500

 

Camarco (PR)

Gordon Poole / James Crothers / Hugo Liddy

 

 

  Tel: +44 (0)20 3781 8331

 

**ENDS**

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFLDIVLDFIL
Date   Source Headline
1st Jul 20107:00 amRNSFinal Results
22nd Apr 20107:00 amRNSDirector/PDMR Shareholding
15th Apr 20101:55 pmRNSAcquisition and Trading Update
26th Jan 20103:40 pmRNSDirector/PDMR Shareholding
25th Jan 20102:07 pmRNSDirectorate Change
18th Dec 20094:28 pmRNSHolding(s) in Company
17th Dec 20092:24 pmRNSHolding(s) in Company
15th Dec 20097:00 amRNSAcquisition
4th Dec 20093:07 pmRNSReplacement: Director/PDMR Shareholding
2nd Dec 20097:00 amRNSDirector/PDMR Shareholding
1st Dec 20097:00 amRNSInterim Results
1st Dec 20097:00 amRNSAcquisition
22nd Sep 200912:28 pmRNSAnnual Financial Report
29th Jul 200912:14 pmRNSAnnual General Meeting
16th Jun 20097:00 amRNSPreliminary Results
3rd Mar 20093:50 pmRNSHolding(s) in Company
3rd Mar 20092:40 pmRNSHolding(s) in Company
2nd Mar 20095:11 pmRNSHolding(s) in Company
2nd Mar 20094:00 pmRNSHolding(s) in Company
2nd Mar 20098:05 amRNSDirector/PDMR Shareholding
26th Feb 20092:02 pmRNSResult of General Meeting
10th Feb 20094:35 pmRNSPrice Monitoring Extension
10th Feb 20097:00 amRNSIssue of Equity
19th Nov 20087:01 amRNSInterim Results
29th Oct 20087:01 amRNSTrading Statement
10th Oct 20084:52 pmRNSSecond Price Monitoring Extn
10th Oct 20084:41 pmRNSPrice Monitoring Extension
7th Oct 20089:39 amRNSHolding(s) in Company
25th Sep 20089:52 amRNSAnnual Report and Accounts
10th Sep 20085:36 pmRNSHolding(s) in Company
1st Sep 20087:30 amRNSDirectorate Change
18th Aug 20083:00 pmRNSDisposal of investment proper
30th Jul 20082:39 pmRNSDirector/PDMR Shareholding
30th Jul 200810:59 amRNSQ1 Update and Result of EGM
10th Jul 200811:45 amRNSDirector/PDMR Shareholding
8th Jul 20089:17 amRNSNotice of EGM
30th Jun 20083:02 pmRNSDirectorate Change
19th Jun 20087:00 amRNSPreliminary Results
29th Apr 20084:54 pmRNSChange of registered address
15th Apr 20082:06 pmRNSWebsite Address
14th Apr 20084:00 pmRNSChange of name effective
14th Apr 20082:03 pmRNSResult of AGM/Change of name
7th Apr 20082:54 pmRNSDirector/PDMR Shareholding
7th Apr 200812:45 pmRNSDirector/PDMR Shareholding
12th Mar 20088:00 amRNSDirector/PDMR Shareholding
11th Mar 200811:37 amRNSDirector/PDMR Shareholding
11th Mar 20087:02 amRNSFinal Results
1st Feb 200812:14 pmRNSHolding(s) in Company
1st Feb 20087:00 amRNSTrading Statement
16th Jan 200812:22 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.